240 related articles for article (PubMed ID: 28931878)
1. A method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis.
Wang JR; Gao WN; Grimm R; Jiang S; Liang Y; Ye H; Li ZG; Yau LF; Huang H; Liu J; Jiang M; Meng Q; Tong TT; Huang HH; Lee S; Zeng X; Liu L; Jiang ZH
Nat Commun; 2017 Sep; 8(1):631. PubMed ID: 28931878
[TBL] [Abstract][Full Text] [Related]
2. N-Linked Glycans in the Variable Domain of IgG Anti-Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis.
Hafkenscheid L; de Moel E; Smolik I; Tanner S; Meng X; Jansen BC; Bondt A; Wuhrer M; Huizinga TWJ; Toes REM; El-Gabalawy H; Scherer HU
Arthritis Rheumatol; 2019 Oct; 71(10):1626-1633. PubMed ID: 31067000
[TBL] [Abstract][Full Text] [Related]
3. On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis.
Kissel T; van Schie KA; Hafkenscheid L; Lundquist A; Kokkonen H; Wuhrer M; Huizinga TW; Scherer HU; Toes R; Rantapää-Dahlqvist S
Ann Rheum Dis; 2019 Dec; 78(12):1616-1620. PubMed ID: 31471298
[TBL] [Abstract][Full Text] [Related]
4. Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.
Rombouts Y; Willemze A; van Beers JJ; Shi J; Kerkman PF; van Toorn L; Janssen GM; Zaldumbide A; Hoeben RC; Pruijn GJ; Deelder AM; Wolbink G; Rispens T; van Veelen PA; Huizinga TW; Wuhrer M; Trouw LA; Scherer HU; Toes RE
Ann Rheum Dis; 2016 Mar; 75(3):578-85. PubMed ID: 25587188
[TBL] [Abstract][Full Text] [Related]
5. IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.
Lundström SL; Fernandes-Cerqueira C; Ytterberg AJ; Ossipova E; Hensvold AH; Jakobsson PJ; Malmström V; Catrina AI; Klareskog L; Lundberg K; Zubarev RA
PLoS One; 2014; 9(11):e113924. PubMed ID: 25426976
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis.
Magorivska I; Döncző B; Dumych T; Karmash A; Boichuk M; Hychka K; Mihalj M; Szabó M; Csánky E; Rech J; Guttman A; Vari SG; Bilyy R
Autoimmunity; 2018 May; 51(3):111-117. PubMed ID: 29733234
[TBL] [Abstract][Full Text] [Related]
7. Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.
Stümer J; Biermann MHC; Knopf J; Magorivska I; Kastbom A; Svärd A; Janko C; Bilyy R; Schett G; Sjöwall C; Herrmann M; Muñoz LE
Clin Exp Immunol; 2017 Sep; 189(3):372-382. PubMed ID: 28509333
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
9. Distribution of abnormal IgG glycosylation patterns from rheumatoid arthritis and osteoarthritis patients by MALDI-TOF-MS
Sun D; Hu F; Gao H; Song Z; Xie W; Wang P; Shi L; Wang K; Li Y; Huang C; Li Z
Analyst; 2019 Mar; 144(6):2042-2051. PubMed ID: 30714583
[TBL] [Abstract][Full Text] [Related]
10. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans.
Omtvedt LA; Royle L; Husby G; Sletten K; Radcliffe CM; Harvey DJ; Dwek RA; Rudd PM
Arthritis Rheum; 2006 Nov; 54(11):3433-40. PubMed ID: 17075835
[TBL] [Abstract][Full Text] [Related]
11. Comparison of anti-agalactosyl IgG antibodies, rheumatoid factors, and anti-cyclic citrullinated peptide antibodies in the differential diagnosis of rheumatoid arthritis and its mimics.
Lu MC; Hsieh SC; Lai NS; Li KJ; Wu CH; Yu CL
Clin Exp Rheumatol; 2007; 25(5):716-21. PubMed ID: 18078619
[TBL] [Abstract][Full Text] [Related]
12. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid.
Scherer HU; van der Woude D; Ioan-Facsinay A; el Bannoudi H; Trouw LA; Wang J; Häupl T; Burmester GR; Deelder AM; Huizinga TW; Wuhrer M; Toes RE
Arthritis Rheum; 2010 Jun; 62(6):1620-9. PubMed ID: 20178128
[TBL] [Abstract][Full Text] [Related]
13. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
14. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation.
Falkenburg WJJ; Kempers AC; Dekkers G; Ooijevaar-de Heer P; Bentlage AEH; Vidarsson G; van Schaardenburg D; Toes REM; Scherer HU; Rispens T
Rheumatology (Oxford); 2017 Nov; 56(11):2025-2030. PubMed ID: 28977504
[TBL] [Abstract][Full Text] [Related]
16. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis.
Rombouts Y; Ewing E; van de Stadt LA; Selman MH; Trouw LA; Deelder AM; Huizinga TW; Wuhrer M; van Schaardenburg D; Toes RE; Scherer HU
Ann Rheum Dis; 2015 Jan; 74(1):234-41. PubMed ID: 24106048
[TBL] [Abstract][Full Text] [Related]
17. Abberant Immunoglobulin G Glycosylation in Rheumatoid Arthritis by LTQ-ESI-MS.
Su Z; Xie Q; Wang Y; Li Y
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192063
[TBL] [Abstract][Full Text] [Related]
18. Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10 years of follow-up.
Gudelj I; Salo PP; Trbojević-Akmačić I; Albers M; Primorac D; Perola M; Lauc G
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2034-2039. PubMed ID: 29572115
[TBL] [Abstract][Full Text] [Related]
19. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
[TBL] [Abstract][Full Text] [Related]
20. Superior specificity of anti-citrullinated peptide antibodies in patients with chronic lymphocytic leukemia and arthritis.
Brickmann K; Brezinschek RI; Yazdani-Biuki B; Graninger WB; Brezinschek HP
Clin Exp Rheumatol; 2010; 28(6):888-91. PubMed ID: 21205465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
